Rituximab Doesn't Alleviate Sjögren Symptoms at Week 24 Monthly Prescribing Reference (HealthDay News) — For patients with primary Sjögren syndrome (pSS), rituximab does not improve symptoms or disease activity at 24 weeks, according to a study published in the February 18 issue of the Annals of Internal Medicine. |
